NASDAQ:SAGE   Sage Therapeutics, Inc.
Big volume, end of the day Sep 17 shows that nstitutionals are buying.
There is a reason: SAGE receives Fast Track Designation for SAGE-718 for the Treatment of Huntington’s Disease
Technically looks strong: cap and handle pattern is bullish

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。